Clinical Pediatric Emergency Medicine
Volume 10, Issue 3 , Pages 136-139 , September 2009

Preparation for Terrorist Threats: Radiation Injury

  • David Siegel, MD, FAAP

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: David Siegel, MD, FAAP, National Institute of Child Health, and Human Development, National Institutes of Health, US Department of Health and Human Services, 6100 Executive Blvd, Room 4A01, MSC 2440, Bethesda, MD 20892-2440.

References 

  1. Quinn M. Pediatric emergency training program: radiological incidents. Washington DC: Children's National Medical Center; 2004;
  2. Walker RI, Willemze R. Neutrophil kinetics and regulation of granulopoiesis. Rev Infect Dis. 1980;2:282–293
  3. Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol. 2007;18:817–826
  4. Nasilowska-Adamska B, Rzepecki P, Manko J, et al. The influence of palifermin on oral mucositis and acute graft versus host disease in patients with hematological disorders undergoing hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;40:983–988
  5. Hall EJ, Garcia AJ. Acute effects of total body irradiation. In: Radiobiology for the radiologist. Philadelphia (Pa): Lippincott Williams & Wilkins; 2006;p. 117–128
  6. Barabanova AV. Acute radiation syndrome with cutaneous syndrome. In:  Ricks RC,  Berger ME,  O'Hara FM editor. The medical basis for radiation accident preparedness: the clinical care of victims. Boca Raton, FL: CRC Press-Parthenon Publishers; 2002;
  7. Marks LB, Yu X, Vujaskovic Z, Small W, et al. Radiation-induced lung injury. Semin Radiat Oncol. 2003;13:333–345
  8. Abratt RP, Morgan GW, Silvestri G, et al. Pulmonary complications of radiation therapy. Clin Chest Med. 2004;25:167–177
  9. Hill RP. Radiation effects on the respiratory system. BJR Suppl. 2005;27:75–81
  10. Molteni A, Moulder JE, Cohen EF, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol. 2000;76:523–532
  11. Cohen EP, Bonsib SA, Whitehouse E, et al. Mediators and mechanisms of radiation nephropathy. Proc Soc Exper Biol Med. 2000;223:218–225
  12. Robbins ME, Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2006;64:6–12
  13. Siegel D, Shannon M, Henretig F, et al. Biodefense meeting: Best Pharmaceuticals for Children Act (BPCA). Eunice Kennedy Shriver National Institute of Child Health and Human Development. Available at: http://bpca.nichd.nih.gov/outreach/upload/Biodefense-09-08.pdfAccessed 7/14/09

PII: S1522-8401(09)00061-5

doi: 10.1016/j.cpem.2009.07.007

Clinical Pediatric Emergency Medicine
Volume 10, Issue 3 , Pages 136-139 , September 2009

Article Tools